BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 19834276)

  • 1. Refractory plasmablastic type myeloma with multiple extramedullary plasmacytomas and massive myelomatous effusion: remarkable response with a combination of thalidomide and dexamethasone.
    Nakazato T; Suzuki K; Mihara A; Sanada Y; Kakimoto T
    Intern Med; 2009; 48(20):1827-32. PubMed ID: 19834276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of extramedullary plasmablastic plasmacytoma successfully treated using a combination of thalidomide and dexamethasone and a review of the medical literature.
    Sekiguchi Y; Asahina T; Shimada A; Imai H; Wakabayashi M; Sugimoto K; Nakamura N; Sawada T; Komatsu N; Noguchi M
    J Clin Exp Hematop; 2013; 53(1):21-8. PubMed ID: 23801130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelomatous pleural effusion.
    Ghosh S; Gopal R; Advani SH
    J Assoc Physicians India; 2006 Sep; 54():738-9. PubMed ID: 17212026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pomalidomide-dexamethasone for treatment of soft-tissue plasmacytomas in patients with relapsed / refractory multiple myeloma.
    Jiménez-Segura R; Granell M; Gironella M; Abella E; García-Guiñón A; Oriol A; Cabezudo E; Clapés V; Soler JA; Escoda L; López-Pardo J; Fernández de Larrea C; Cibeira MT; Tovar N; Isola I; Bladé J; Rosiñol L;
    Eur J Haematol; 2019 May; 102(5):389-394. PubMed ID: 30719772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral melphalan, dexamethasone, and thalidomide for the treatment of refractory multiple myeloma.
    Asou N; Izuno Y; Okubo T; Ide K; Ueno H; Kawakita M; Mitsuya H; Hata H
    Int J Hematol; 2007 Jul; 86(1):69-71. PubMed ID: 17675270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A clinical analysis of 25 cases of multiple myeloma complicated by extramedullary plasmacytomas].
    Zhong YP; Chen SL
    Zhonghua Nei Ke Za Zhi; 2009 May; 48(5):396-8. PubMed ID: 19615158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid response of plasmacytomas to lenalidomide plus low-dose dexamethasone therapy in a patient with relapsed multiple myeloma.
    Fukushima T; Nakamura T; Iwao H; Umehara H
    Am J Hematol; 2011 Oct; 86(10):893. PubMed ID: 21812018
    [No Abstract]   [Full Text] [Related]  

  • 8. Response of the extramedullary lung plasmacytoma with pleural effusion to chemotherapy.
    Nagai K; Ando K; Yoshida H; Kusaka S; Hinuma Y; Hakamata Y; Ishii K; Kume N; Ochi H; Wakatsuki Y; Yokode M; Murakami M; Kita T
    Ann Hematol; 1997 Jun; 74(6):279-81. PubMed ID: 9236513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bortezomib in combination with thalidomide and dexamethasone--a successful treatment regimen in refractory extramedullary multiple myeloma.
    Dytfeld D; Matuszak M; Lewandowski K; Komarnicki M
    Ann Hematol; 2008 Mar; 87(3):253-4. PubMed ID: 17955241
    [No Abstract]   [Full Text] [Related]  

  • 10. IgG myeloma presenting as a large mediastinal mass and pleural effusion.
    Raci-Wetherbee E; Dincer HE
    J Bronchology Interv Pulmonol; 2012 Jan; 19(1):65-7. PubMed ID: 23207268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bortezomib in relapsed multiple myeloma complicated by extramedullary plasmacytomas.
    Hughes M; Micallef-Eynaud P
    Clin Lab Haematol; 2006 Aug; 28(4):267-9. PubMed ID: 16898968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The oral combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) is effective in relapsed/refractory multiple myeloma.
    García-Sanz R; González-Porras JR; Hernández JM; Polo-Zarzuela M; Sureda A; Barrenetxea C; Palomera L; López R; Grande-García C; Alegre A; Vargas-Pabón M; Gutiérrez ON; Rodríguez JA; San Miguel JF
    Leukemia; 2004 Apr; 18(4):856-63. PubMed ID: 14973508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solitary bone plasmacytoma terminally developed myeloma with multiple extramedullary lesions and myelomatous pleural effusion and ascites.
    Matsumoto A; Nagata K; Hamaguchi H; Taki K
    Int J Hematol; 1993 Dec; 59(1):59-65. PubMed ID: 8161736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant myelomatous pleural effusion with good response to combination chemotherapy.
    Attili VS; Singh VP; Sundar S; Mehta H; Negi ML; Gogia A; Raju SH; Rai M
    J Assoc Physicians India; 2007 Aug; 55():595-6. PubMed ID: 18019805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dose thalidomide in patients with relapsed or refractory multiple myeloma.
    Kees M; Dimou G; Sillaber C; Drach J; Ackermann J; Lechner K; Gisslinger H
    Leuk Lymphoma; 2003 Nov; 44(11):1943-6. PubMed ID: 14738147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of relapsed multiple myeloma complicated by cardiac extramedullary plasmacytoma with D-PACE chemotherapy.
    Toocheck C; Pinkhas D
    BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29523615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two cases of permanent indwelling catheter for long-term administration of intrapleural chemotherapy.
    Lázaro Sierra J; Carrasco V; Cases E; Gómez Gonzalez C
    Arch Bronconeumol; 2017 Oct; 53(10):590-591. PubMed ID: 28359605
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: a report of the Greek myeloma study group in 97 patients.
    Katodritou E; Terpos E; Symeonidis AS; Pouli A; Kelaidi C; Kyrtsonis MC; Kotsopoulou M; Delimpasi S; Christoforidou A; Giannakoulas N; Viniou NA; Stefanoudaki E; Hadjiaggelidou C; Christoulas D; Verrou E; Gastari V; Papadaki S; Polychronidou G; Papadopoulou A; Giannopoulou E; Kastritis E; Kouraklis A; Konstantinidou P; Anagnostopoulos A; Zervas K; Dimopoulos MA
    Am J Hematol; 2014 Aug; 89(8):803-8. PubMed ID: 24757085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of extramedullary plasmacytoma of the cavernous sinus using a combination of intermediate dose of thalidomide and dexamethasone.
    Katodritou E; Speletas M; Pouli A; Tsitouridis J; Zervas K; Terpos E
    Acta Haematol; 2007; 117(1):20-3. PubMed ID: 17106187
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination of bortezomib, thalidomide, and dexamethasone in the treatment of relapsed, refractory IgD multiple myeloma.
    Schmielau J; Teschendorf C; König M; Schmiegel W; Graeven U
    Leuk Lymphoma; 2005 Apr; 46(4):567-9. PubMed ID: 16019485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.